KR20030059115A - Ｎ-아릴-안트라닐산 및 그의 유도체의 제조 방법 - Google Patents

Ｎ-아릴-안트라닐산 및 그의 유도체의 제조 방법 Download PDF

Info

Publication number
KR20030059115A
KR20030059115A KR10-2003-7002675A KR20037002675A KR20030059115A KR 20030059115 A KR20030059115 A KR 20030059115A KR 20037002675 A KR20037002675 A KR 20037002675A KR 20030059115 A KR20030059115 A KR 20030059115A
Authority
KR
South Korea
Prior art keywords
formula
compound
alkyl
hydrogen
group
Prior art date
Application number
KR10-2003-7002675A
Other languages
English (en)
Korean (ko)
Inventor
마이클 후아이 구 첸
에드워드 마크 다비스
자비어 마가노
토마스 노르만 난닌가
데릭 데일 윈클
Original Assignee
워너-램버트 캄파니 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 워너-램버트 캄파니 엘엘씨 filed Critical 워너-램버트 캄파니 엘엘씨
Publication of KR20030059115A publication Critical patent/KR20030059115A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/10—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04—Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C07C227/08—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid by reaction of ammonia or amines with acids containing functional groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
KR10-2003-7002675A 2000-08-25 2001-07-20 Ｎ-아릴-안트라닐산 및 그의 유도체의 제조 방법 KR20030059115A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22820600P 2000-08-25 2000-08-25
US60/228,206 2000-08-25
PCT/US2001/022948 WO2002018319A1 (en) 2000-08-25 2001-07-20 Process for making n-aryl-anthranilic acids and their derivatives

Publications (1)

Publication Number Publication Date
KR20030059115A true KR20030059115A (ko) 2003-07-07

Family

ID=22856235

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2003-7002675A KR20030059115A (ko) 2000-08-25 2001-07-20 Ｎ-아릴-안트라닐산 및 그의 유도체의 제조 방법

Country Status (31)

Country Link
EP (1) EP1313694A1 (no)
JP (1) JP2004507518A (no)
KR (1) KR20030059115A (no)
CN (1) CN1458921A (no)
AP (1) AP2001002249A0 (no)
AR (1) AR032175A1 (no)
AU (1) AU2001277044A1 (no)
BG (1) BG107635A (no)
BR (1) BR0113520A (no)
CA (1) CA2420003A1 (no)
CZ (1) CZ2003477A3 (no)
DO (1) DOP2001000238A (no)
EA (1) EA200300187A1 (no)
GT (1) GT200100174A (no)
HN (1) HN2001000216A (no)
HU (1) HUP0300828A2 (no)
IL (1) IL154507A0 (no)
IS (1) IS6724A (no)
MA (1) MA26949A1 (no)
MX (1) MXPA03001654A (no)
NO (1) NO20030844L (no)
PA (1) PA8526501A1 (no)
PE (1) PE20020393A1 (no)
PL (1) PL360699A1 (no)
SK (1) SK2072003A3 (no)
SV (1) SV2002000601A (no)
TN (1) TNSN01127A1 (no)
UY (1) UY26908A1 (no)
WO (1) WO2002018319A1 (no)
YU (1) YU14303A (no)
ZA (1) ZA200301182B (no)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235537B2 (en) 2002-03-13 2007-06-26 Array Biopharma, Inc. N3 alkylated benzimidazole derivatives as MEK inhibitors
ES2549159T3 (es) 2002-03-13 2015-10-23 Array Biopharma, Inc. Derivados de bencimidazol N3-alquilados como inhibidores de MEK
US7144907B2 (en) 2003-09-03 2006-12-05 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
US7538120B2 (en) 2003-09-03 2009-05-26 Array Biopharma Inc. Method of treating inflammatory diseases
AU2004283148A1 (en) 2003-10-21 2005-05-06 Warner-Lambert Company Llc Polymorphic form of N-[(R)-2,3-Dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
DK1689233T3 (da) 2003-11-19 2012-10-15 Array Biopharma Inc Bicykliske inhibitorer af MEK
US7732616B2 (en) 2003-11-19 2010-06-08 Array Biopharma Inc. Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof
US7517994B2 (en) 2003-11-19 2009-04-14 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
KR101223914B1 (ko) 2003-11-21 2013-01-18 어레이 바이오파마 인크. Ａｋｔ 단백질 키나제 억제제
UA89035C2 (ru) * 2003-12-03 2009-12-25 Лео Фарма А/С Эфиры гидроксамовых кислот и их фармацевтическое применение
WO2006109085A1 (en) 2005-04-13 2006-10-19 Astex Therapeutics Limited Hydroxybenzamide derivatives and their use as inhibitors of hsp90
ES2333182T3 (es) 2005-05-18 2010-02-17 Array Biopharma, Inc. Derivados de 4-(fenilamino)-6-oxo-1,6-dihidropiridazina-3-carboxamida como inhibidores de mek para el tratamiento de enfermedades hiperproliferativas.
US7754725B2 (en) 2006-03-01 2010-07-13 Astex Therapeutics Ltd. Dihydroxyphenyl isoindolymethanones
RU2481336C2 (ru) 2006-07-06 2013-05-10 Эррэй Биофарма Инк. Циклопента(d)пиримидины в качестве ингибиторов протеинкиназ акт
CN101511842B (zh) 2006-07-06 2012-10-31 阵列生物制药公司 作为akt蛋白激酶抑制剂的二氢呋喃并嘧啶
US8063050B2 (en) 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
CN101516891B (zh) 2006-07-06 2013-06-05 阵列生物制药公司 作为akt蛋白激酶抑制剂的二氢噻吩并嘧啶
WO2008044054A2 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Hydroxy-substituted benzoic acid amide compounds for use in therapy
GB0620259D0 (en) 2006-10-12 2006-11-22 Astex Therapeutics Ltd Pharmaceutical compounds
JP5528806B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
US8779132B2 (en) 2006-10-12 2014-07-15 Astex Therapeutics Limited Pharmaceutical compounds
JP5721949B2 (ja) 2006-10-12 2015-05-20 アステックス、セラピューティックス、リミテッドＡｓｔｅｘ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ 複合薬剤
WO2008044045A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
BRPI0813993A2 (pt) 2007-07-05 2015-06-16 Array Biopharma Inc Ciclopentanos de pirimidila como inibidores de proteína quinase akt
US8846683B2 (en) 2007-07-05 2014-09-30 Array Biopharma, Inc. Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
US9409886B2 (en) 2007-07-05 2016-08-09 Array Biopharma Inc. Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
RU2486181C2 (ru) 2007-07-05 2013-06-27 Эррэй Биофарма Инк. Пиримидилциклопентаны как ингибиторы акт-протеинкиназ
NZ586346A (en) 2008-01-09 2012-02-24 Array Biopharma Inc Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
NZ586720A (en) 2008-01-09 2012-11-30 Array Biopharma Inc Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor
GB0806527D0 (en) 2008-04-11 2008-05-14 Astex Therapeutics Ltd Pharmaceutical compounds
CN101985428B (zh) * 2009-07-29 2014-02-12 杭州民生药业有限公司 邻苯胺基苯甲酸衍生物或其药学上可接受的盐、其制备方法及其用途
US20120316337A1 (en) * 2010-02-19 2012-12-13 Universite Du Maine Method for preparing chemical compounds of interest by nucleophilic aromatic substitution of aromatic carboxylic acid derivatives supporting at least one electro-attractive group
EP2536682A1 (fr) * 2010-02-19 2012-12-26 Centre National De La Recherche Scientifique Procede de preparation de composes chimiques d'interet par substitution nucleophile aromatique de derives d'acides carboxyliques aromatiques portant au moins un groupement electroattracteur
CN103857395A (zh) 2011-04-01 2014-06-11 基因泰克公司 Akt抑制剂化合物和阿比特龙的组合及使用方法
KR20140022053A (ko) 2011-04-01 2014-02-21 제넨테크, 인크. Akt 및 mek 억제제 화합물의 조합물, 및 사용 방법
CR20200237A (es) * 2012-10-12 2020-07-26 Exelixis Inc Proceso novedoso para la elaboración de compuestos para su uso en el tratamiento del cáncer (diviisional 2015-0245)
CN112745237B (zh) * 2019-10-29 2023-06-20 中国科学院上海药物研究所 2-芳基胺类化合物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3138636A (en) * 1960-06-23 1964-06-23 Parke Davis & Co Anthranilic acid derivatives
US6251943B1 (en) * 1997-02-28 2001-06-26 Warner-Lambert Company Method of treating or preventing septic shock by administering a MEK inhibitor
EP0993437B1 (en) * 1997-07-01 2006-11-08 Warner-Lambert Company Llc 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors
ES2229515T3 (es) * 1997-07-01 2005-04-16 Warner-Lambert Company Llc Derivados 4-bromo o 4-yodo del acido fenilamino benzhidroxamico y su uso como inhibidores de la mek.
CA2348236A1 (en) * 1999-01-13 2000-07-20 Stephen Douglas Barrett 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors
YU73701A (sh) * 1999-04-21 2005-06-10 Warner-Lambert Company Postupak pripremanja 2-(n-fenilamino)benzoevih kiselina

Also Published As

Publication number Publication date
MA26949A1 (fr) 2004-12-20
HUP0300828A2 (hu) 2003-09-29
AP2001002249A0 (en) 2001-09-30
EA200300187A1 (ru) 2003-08-28
CN1458921A (zh) 2003-11-26
GT200100174A (es) 2002-07-18
DOP2001000238A (es) 2003-01-31
BG107635A (bg) 2004-09-30
CA2420003A1 (en) 2002-03-07
WO2002018319A1 (en) 2002-03-07
PE20020393A1 (es) 2002-05-09
JP2004507518A (ja) 2004-03-11
PL360699A1 (en) 2004-09-20
MXPA03001654A (es) 2004-09-10
BR0113520A (pt) 2003-06-24
PA8526501A1 (es) 2002-07-30
UY26908A1 (es) 2001-11-30
YU14303A (sh) 2006-08-17
EP1313694A1 (en) 2003-05-28
IL154507A0 (en) 2003-09-17
IS6724A (is) 2003-02-20
AU2001277044A1 (en) 2002-03-13
TNSN01127A1 (en) 2005-11-10
SK2072003A3 (en) 2004-01-08
HN2001000216A (es) 2002-05-22
ZA200301182B (en) 2004-05-12
CZ2003477A3 (cs) 2003-10-15
AR032175A1 (es) 2003-10-29
SV2002000601A (es) 2002-04-03
NO20030844D0 (no) 2003-02-24
NO20030844L (no) 2003-02-25

Similar Documents

Publication Publication Date Title
KR20030059115A (ko) Ｎ-아릴-안트라닐산 및 그의 유도체의 제조 방법
TWI801465B (zh) 製備囊性纖維化跨膜傳導調控劑之調節劑之方法
EP2185510B1 (en) New salts of bazedoxifene
EP2266991B1 (en) Process for producing thiazole derivative
NZ571142A (en) Synthesis of acylaminoalkenylene amides such as (4R)-4-[N'-methyl-N'-(3,5-bistrifluoromethyl-benzoyl)-amino]-4(-3,4-dichlorobenzyl)-but-2-enoic acid N-[(R)-epsilon-caprolactam-3-yl]-amide hemihydrate useful as substance P antagonists
US20130060038A1 (en) Preparation of dihydropyrrol derivatives as intermediates
US20040039208A1 (en) Process for making n-aryl-anthranilic acids and their derivatives
JP2021504418A (ja) ２−（５−メトキシイソクロマン−１−イル）−４，５−ジヒドロ−１ｈ−イミダゾールおよびその硫酸水素塩の製造方法
CA2543250C (en) Process for the preparation of ccr-2 antagonist
EP1889827B1 (en) Process for producing [2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine
JP2006348034A (ja) Ｍｅｋ阻害剤の製造方法
TWI724031B (zh) 製備1-(4-甲烷磺醯基-2-三氟甲基-苄基)-2-甲基-1h-吡咯并[2,3-b]吡啶-3-基-乙酸之方法
EP3097082B1 (en) Processes for the synthesis of substituted urea compounds
KR20060020082A (ko) 2-아미노피리딘 유도체의 제조방법
CA3214107A1 (en) New process for the synthesis of 5-{5-chloro-2-[(3s)-3- [(morpholin-4-yl)methyl]-3,4-dihydroisoquinoline-2(1h)- carbonyl]phenyl}-1,2-dimethyl-1h-pyrrole-3-carboxylic acid derivatives and its application for the production of pharmaceutical compounds
JP2013544787A (ja) アザインダゾール誘導体の調製方法
CN110494417B (zh) N-取代的芳族羟胺的生产
EP0701558A1 (en) Process of making spirocycles and analogs thereof
JP2641879B2 (ja) 光学活性を有するヒダントイン誘導体の製法
JP2002053552A (ja) ４，６−ジメチルインドール及びその誘導体の製造方法
KR101695346B1 (ko) 이보두탄트（ｍｅｎ15596）및 관련 중간체의 제조 방법
US20040181070A1 (en) Process and intermediates for the preparation of 4-aryl piperidines
TW202237594A (zh) 製造5-(4-((2s,5s)-5-(4-氯芐基)-2-甲基嗎啉基)哌啶-1-基)-1h-1,2,4-三唑-3-胺的方法
AU2003249262A1 (en) Process for the preparation of imidazo(1,2-a)pyridine-3-acetamides
JPH03190854A (ja) インダン誘導体の製法及びその合成中間体

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid